Eagle Pharmaceuticals is Pharmaceuticals in United States that focus on Eagle Pharmaceuticals Inc business. Founded in 2007. They cover business area such as Eagle Pharmaceuticals Inc, injectable product, critical care, orphan disease, oncology, its product portfolio, four approve product, Argatroban, Ryanodex, Belrapzo, Bendeka, multiple product candidate, advanced stage, development, review, approval.
2007
( 17 years old in 2024 )
Eagle Pharmaceuticals Inc
-
50 Tice Boulevard
Suite 315
Woodcliff Lake, NJ 07677
United States
Private
Eagle Pharmaceuticals Incinjectable productcritical careorphan diseaseoncologyits product portfoliofour approve productArgatrobanRyanodexBelrapzoBendekamultiple product candidateadvanced stagedevelopmentreviewapproval
* We use standard office opening hours in near Eagle Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Eagle Pharmaceuticals is Pharmaceuticals business from United States that founded in 2007 (17 years old in 2024), Eagle Pharmaceuticals business is focusing on Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals headquarter office and corporate office address is located in 50 Tice Boulevard Suite 315 Woodcliff Lake, NJ 07677 United States.
Eagle Pharmaceuticals was founded in United States.
In 2024, Eagle Pharmaceuticals is currently focus on Eagle Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Eagle Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Eagle Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
